1	Effects	Effect	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	prostaglandin	prostaglandin	_	_	_	_	_	_	_
4	E2	e2	_	_	_	_	_	_	_
5	on	on	_	_	_	_	_	_	_
6	Th0-type	th0-type	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	clones	clone	_	_	_	_	_	_	_
11	:	:	_	_	_	_	_	_	_
12	modulation	modulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	functions	function	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	proteins	protein	_	_	_	_	_	_	_
18	involved	involve	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	cytokine	cytokine	_	_	_	_	_	_	_
21	production	production	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	prostaglandin	prostaglandin	_	_	_	_	_	_	_
5	E2	e2	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	PGE2	pge2	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	cytokine	cytokine	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	proliferation	proliferation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	CD4+	cd4+	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	helper	helper	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	clone	clone	_	_	_	_	_	_	_
22	SP-B21	sp-b21	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	investigated	investigate	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	stimulated	stimulate	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	anti-CD3	anti-cd3	_	_	_	_	_	_	_
6	mAb	mab	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	PGE2	PGE2	_	_	_	_	_	_	_
9	inhibited	inhibit	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	proliferation	proliferation	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	production	production	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	all	all	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	cytokines	cytokine	_	_	_	_	_	_	_
19	examined	examine	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Addition	addition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	rIL-2	ril-2	_	_	_	_	_	_	_
4	fully	fully	_	_	_	_	_	_	_
5	restored	restore	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	proliferative	proliferative	_	_	_	_	_	_	_
8	response	response	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	partially	partially	_	_	_	_	_	_	_
11	restored	restore	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	IL-4	il-4	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	IL-5	il-5	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	but	but	_	_	_	_	_	_	_
20	not	not	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	other	other	_	_	_	_	_	_	_
24	cytokines	cytokine	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	stimulated	stimulate	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	phorbol	phorbol	_	_	_	_	_	_	_
9	myristate	myristate	_	_	_	_	_	_	_
10	acetate	acetate	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	PMA)/A23187	PMA)/A23187	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	PGE2	PGE2	_	_	_	_	_	_	_
15	enhanced	enhance	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	production	production	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	IL-4	il-4	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	IL-5	il-5	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	only	only	_	_	_	_	_	_	_
25	partially	partially	_	_	_	_	_	_	_
26	inhibited	inhibit	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	production	production	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	other	other	_	_	_	_	_	_	_
31	cytokines	cytokine	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	effects	effect	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	PGE2	pge2	_	_	_	_	_	_	_
7	vary	vary	_	_	_	_	_	_	_
8	depending	depend	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	mode	mode	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	IL-4	il-4	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	IL-5	il-5	_	_	_	_	_	_	_
22	are	be	_	_	_	_	_	_	_
23	regulated	regulate	_	_	_	_	_	_	_
24	differently	differently	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	other	other	_	_	_	_	_	_	_
27	cytokines	cytokine	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	mobility	mobility	_	_	_	_	_	_	_
4	shift	shift	_	_	_	_	_	_	_
5	assay	assay	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	only	only	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	p50/p50	p50/p50	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	homodimer	homodimer	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	observed	observe	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	complex	complex	_	_	_	_	_	_	_
20	formed	form	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	kappa	kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	sequence	sequence	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	unstimulated	unstimulated	_	_	_	_	_	_	_
28	SP-B21	sp-b21	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	stimulated	stimulate	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	anti-CD3	anti-cd3	_	_	_	_	_	_	_
7	mAb	mab	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	PMA/A23187	PMA/A23187	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	complex	complex	_	_	_	_	_	_	_
13	formation	formation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	p50/p65	p50/p65	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	heterodimer	heterodimer	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	kappa	kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	sequence	sequence	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	induced	induce	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	PGE2	pge2	_	_	_	_	_	_	_
4	or	or	_	_	_	_	_	_	_
5	di-butyryl	di-butyryl	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	Bt2)cAMP	Bt2)cAMP	_	_	_	_	_	_	_
8	abolished	abolish	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	p50/p65	p50/p65	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	heterodimer	heterodimer	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	kappa	kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	sequence	sequence	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	stimulated	stimulate	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	anti-CD3	anti-cd3	_	_	_	_	_	_	_
28	mAb	mab	_	_	_	_	_	_	_
29	but	but	_	_	_	_	_	_	_
30	not	not	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	PMA/A23187	PMA/A23187	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	target	target	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	PGE2	pge2	_	_	_	_	_	_	_
9	action	action	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	component	component	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	signal	signal	_	_	_	_	_	_	_
16	transduction	transduction	_	_	_	_	_	_	_
17	pathway	pathway	_	_	_	_	_	_	_
18	leading	lead	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	kinase	kinase	_	_	_	_	_	_	_
25	C	C	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	inhibition	inhibition	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	signals	signal	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	PGE2	pge2	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	selective	selective	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	PGE2	PGE2	_	_	_	_	_	_	_
2	enhanced	enhance	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	complex	complex	_	_	_	_	_	_	_
5	formation	formation	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	NF-AT	NF-AT	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	CLE0	cle0	_	_	_	_	_	_	_
12	sequences	sequence	_	_	_	_	_	_	_
13	when	when	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	activated	activate	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	either	either	_	_	_	_	_	_	_
20	anti-CD3	anti-cd3	_	_	_	_	_	_	_
21	mAb	mab	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	PMA/A23187	pma/a23187	_	_	_	_	_	_	_
24	stimulation	stimulation	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	seems	seem	_	_	_	_	_	_	_
3	therefore	therefore	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	PGE2	pge2	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	elevating	elevate	_	_	_	_	_	_	_
9	cAMP	camp	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	interferes	interfere	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	pathway	pathway	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	NF-kappa	NF-kappa	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	but	but	_	_	_	_	_	_	_
21	not	not	_	_	_	_	_	_	_
22	for	for	_	_	_	_	_	_	_
23	NF-AT	NF-AT	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	AP-1	ap-1	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	CLE0	cle0	_	_	_	_	_	_	_
28	binding	binding	_	_	_	_	_	_	_
29	protein	protein	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

